Complete Elimination of Reflux Symptoms Does not Guarantee Normalization of Intraesophageal and Intragastric pH in Patients with Gastroesophageal Reflux Disease (GERD)

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Gastroenterology

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2004.30124.xPMID 15180715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients

  2003cited by this paper
• Optimizing medical therapy for gastroesophageal reflux disease: state of the art.

  2003cited by this paper
• Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

  2001cited by this paper
• Lessons Learned From Intragastric pH Monitoring

  2001cited by this paper
• Maximal acid reflux control for Barrett’s oesophagus: feasible and effective

  2001cited by this paper
• Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro‐oesophageal reflux disease

  2000cited by this paper
• Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor

  2000cited by this paper
• Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

  2000cited by this paper
• Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

  2000cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus

  1998cited by this paper
• Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.

  1998cited by this paper
• An evidence-based appraisal of reflux disease management — the Genval Workshop Report

  1998cited by this paper
• Gastro‐oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole

  1998cited by this paper
• Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.

  1996cited by this paper
• Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

  1996cited by this paper
• Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

  1994cited by this paper
• Appropriate acid suppression for the management of gastro-oesophageal reflux disease.

  1992cited by this paper
• Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility.

  1992cited by this paper
• Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease.

  1986cited by this paper

• Efficacy of Different Endoscopic Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.

  2024cites this paper
• Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.

  2022cites this paper
• The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease

  2022cites this paper
• Endoscopic Therapies for GERD

  2021cites this paper
• Advances in Endoscopic Management of GERD: A Brief Review on TIF Procedure

  2021cites this paper
• Esophageal Disorders

  2021cites this paper
• Endoscopic Radiofrequency (Stretta) in the Management of Gastroesophageal Reflux Disease (GERD)

  2021cites this paper
• Nonablative Radiofrequency Treatment for Gastroesophageal Reflux Disease (STRETTA).

  2020cites this paper
• Changes in high-resolution manometric diagnosis over time: implications for clinical decision-making.

  2020cites this paper
• Ninety-Six Hour Wireless Esophageal pH Study in Patients with GERD Shows that Restrictive Diet Reduces Esophageal Acid Exposure

  2019cites this paper
• Stretta therapy in the management of gastroesophageal reflux disease (GERD)

  2019cites this paper
• Long-term (15-year) objective evaluation of 150 patients after laparoscopic Nissen fundoplication.

  2019cites this paper
• Clinical, Endoscopic, and Histologic Findings at the Distal Esophagus and Stomach Before and Late (10.5 Years) After Laparoscopic Sleeve Gastrectomy: Results of a Prospective Study with 93% Follow-Up

  2019cites this paper
• Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification

  2018cites this paper
• Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms

  2018cites this paper
• Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.

  2017cites this paper
• Patients with symptoms of delayed gastric emptying have a high prevalence of oesophageal dysmotility, irrespective of scintigraphic evidence of gastroparesis

  2017cites this paper
• Transoral incisionless fundoplication: current status

  2016cites this paper
• Clinical and pH study characteristics in reflux patients with and without ineffective oesophageal motility (IEM)

  2016cites this paper
• Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm

  2016cites this paper
• Endolumenal GERD Therapies

  2016cites this paper
• Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.

  2016cites this paper
• Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.

  2015cites this paper
• Surgical Management of Barrett's Esophagus.

  2015cites this paper
• Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months

  2015influential citation
• Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results

  2015cites this paper
• Randomized Controlled Trial of Transoral Incisionless Fundoplication Vs. Proton Pump Inhibitors for Treatment of Gastroesophageal Reflux Disease

  2015cites this paper
• Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device

  2015cites this paper
• Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy

  2015cites this paper
• Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD

  2015cites this paper
• Patients with refractory reflux symptoms: What do they have and how should they be managed?

  2015cites this paper
• Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease.

  2014cites this paper
• Transoral Incisionless Fundoplication: 2-year Results from the Prospective Multicenter U.S. Study

  2014cites this paper
• Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study

  2014cites this paper
• Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial

  2014cites this paper
• A Suggested Approach

  2014cites this paper
• Refractory gastroesophageal reflux disease

  2014cites this paper
• 950 Dual Ambulatory pH Monitoring in Patients With Gastroesophageal Reflux Rendered Asymptomatic With Proton Pump Inhibitor Therapy

  2014cites this paper
• Laparoscopic Nissen fundoplication in the treatment of Barrett's esophagus – 10 years of experience

  2013influential citation
• Anti-Oxidative and Anti-Inflammatory Effects of QGC in Cultured Feline Esophageal Epithelial Cells

  2013cites this paper
• Diagnosis and Management of Barrett’s Esophagus with and Without Dysplasia

  2013cites this paper
• Gastroprotective activity and mechanism of novel dichlorido-zinc(II)-4-(2-(5-methoxybenzylideneamino)ethyl)piperazin-1-iumphenolate complex on ethanol-induced gastric ulceration.

  2012cites this paper
• Control of intra‐oesophageal pH in patients with Barrett's oesophagus on omeprazole‐sodium bicarbonate therapy

  2012cites this paper
• High‐dose esomeprazole is required for intraesophageal acid control in gastroesophageal reflux disease patients with hiatus hernia

  2012cites this paper
• Potent Gastric Acid Inhibition in the Management of Barrett’s Oesophagus

  2012cites this paper
• Transoral Incisionless Fundoplication Offers High Patient Satisfaction and Relief of Therapy-Resistant Typical and Atypical Symptoms of GERD in Community Practice

  2011cites this paper
• Funktionsdiagnostik bei gastroösophagealer Refluxkrankheit – von der Manometrie über BRAVO und Langzeit-pH-Metrie zur Impedanzmessung

  2011cites this paper
• Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease

  2010cites this paper
• The effects of high‐dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett’s oesophagus

  2010cites this paper
• Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates.

  2010cites this paper
• Lack of Correlation Between a Self-Administered Subjective GERD Questionnaire and Pathologic GERD Diagnosed by 24-h Esophageal pH Monitoring

  2010cites this paper
• Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.

  2010cites this paper
• Efficacy of Three Different Dosages of Esomeprazole in the Long-Term Management of Reflux Disease: A Prospective, Randomized Study, Using the Wireless Bravo pH System

  2010cites this paper
• Disease progression in non-erosive reflux disease (NERD): impact of initial esophageal acid exposure.

  2010cites this paper
• Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.

  2009cites this paper
• Management of heartburn not responding to proton pump inhibitors

  2009cites this paper
• Esophageal-reflux monitoring.

  2009cites this paper
• Medical management of gastroesophageal reflux disease.

  2008cites this paper
• Motilität von Ösophagus und Magen vor und nach minimal-invasiver Fundoplicatio bei Refluxkrankheit: Eine prospektive Analyse szintigraphischer Untersuchungsergebnisse

  2008cites this paper
• Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors

  2008cites this paper
• The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus.

  2008cites this paper
• Acid Reflux Detection and Symptom-Reflux Association Using 4-Day Wireless pH Recording Combining 48-Hour Periods Off and On PPI Therapy

  2008cites this paper
• Esophageal Acid Exposure on Proton Pump Inhibitors in Unselected Asymptomatic Gastroesophageal Reflux Disease Patients

  2008cites this paper
• Multimodal approach to sensations from the esophagus in healthy subjects and in patients with gastro-esophageal reflux disease

  2008influential citation
• Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.

  2007cites this paper
• Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma

  2007cites this paper
• Surgical Management for Gastroesophageal Reflux Disease Series

  2007cites this paper
• New algorithm for the treatment of gastro‐oesophageal reflux disease

  2007cites this paper
• The evolving role of the wireless pH capsule in evaluation of patients with GERD

  2007cites this paper
• ACG Practice Guidelines: Esophageal Reflux Testing

  2007cites this paper
• GERD: New Strategies and New Failures

  2007cites this paper
• Abklärung und Therapie von Refluxbeschwerden

  2006cites this paper
• Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial

  2006cites this paper
• [Symptom- versus endoscopy-based diagnosis and treatment of gastroesophageal reflux disease (GERD)].

  2006cites this paper
• The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.

  2006cites this paper
• Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain.

  2006cites this paper
• Review article: intragastric and oesophageal pH monitoring in patients with gastro‐oesophageal reflux disease

  2006influential citation
• The Prevalence of Distal and Proximal Gastroesophageal Reflux in Patients Awaiting Lung Transplantation

  2006cites this paper
• Review article: modern technology in the diagnosis of gastro‐oesophageal reflux disease – Bilitec, intraluminal impedance and Bravo capsule pH monitoring

  2006cites this paper
• Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance.

  2006cites this paper
• Bravura for Bravo pH monitoring.

  2006cites this paper
• Ambulatory pH Monitoring: New Advances and Indications.

  2006cites this paper
• Klinische Bedeutung des gastroösophagealen Refluxes beim Asthma bronchiale

  2006cites this paper
• Refractory Lpr: Surgery Is Not The Answer

  2006cites this paper
• Multimodal pain stimulations in patients with grade B oesophagitis

  2005cites this paper
• Endoscopic antireflux procedures: a good wrap?

  2005cites this paper
• Proton-pump inhibitor therapy for gastroesophageal reflux disease: does it treat the asthma?

  2005cites this paper
• Robotic laparoscopic fundoplication

  2005cites this paper
• Aktuelle Diagnostik und Therapie der schwach sauren/nicht sauren gastroösophagealen Refluxkrankheit

  2005cites this paper
• [Diagnosis and therapy of weakly-acid/non-acidic gastroesophageal reflux disease].

  2005cites this paper
• Clinical relevance of esophageal and gastric pH measurements in patients with gastro-esophageal reflux disease (GERD)

  2005cites this paper
• Acid normalization and improved esophageal motility after Nissen fundoplication: equivalent outcomes in patients with normal and ineffective esophageal motility.

  2005cites this paper
• Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.

  2005cites this paper
• Minimally Invasive Therapy for GERD - An Update

  2004cites this paper
• Is Normalization of Acid Exposure Necessary in GERD Patients on PPIs

  2004cites this paper
• GERD: The Potential for Endoscopic Intervention

  2004cites this paper
• Acid Inhibition in GERD—How Much is Enough?

  2004influential citation